![]() |
市場調查報告書
商品編碼
2008993
甲狀腺功能檢測市場報告:按檢測類型、適應症、最終用戶和地區分類(2026-2034 年)Thyroid Function Test Market Report by Test Type (TSH Tests, T3 Tests, T4 Tests, and Others), Indication (Hypothyroidism, Hyperthyroidism, Thyroid Cancer, and Others), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2026-2034 |
||||||
2025年全球甲狀腺功能檢測市場規模達18億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到27億美元,2026年至2034年的複合年成長率為4.73%。推動市場成長的因素包括:檢測設備的準確性、速度和可靠性不斷提高的技術進步;家用檢測套組需求的成長;以及人們對甲狀腺疾病早期檢測和治療日益成長的興趣。
診斷技術的進步
自動化檢測系統、高通量分析儀和即時檢測 (POC) 設備等創新技術正在提升甲狀腺檢測的準確性、速度和便利性。這些技術使醫護人員能夠更快地提供檢測結果,從而促進甲狀腺疾病的診斷和治療。此外,人工智慧 (AI) 和機器學習 (ML) 的整合應用,提高了甲狀腺檢測的預測準確性,並提升了個人化治療的品質。家用檢測套組的發展也簡化了甲狀腺健康監測流程,尤其方便了居住在偏遠地區或行動不便的患者。這些檢測技術的進步推動了醫療機構對甲狀腺功能檢測的需求。 2023 年,Cipla 推出了 Cippoint,這是一款即時檢測設備,可快速檢測包括心臟標記、糖尿病和甲狀腺功能在內的多種健康問題。這款獲得 CE IVD 認證的設備可在 3 至 15 分鐘內提供檢測結果,有助於加快臨床決策。 Cippoint 的開發著重易用性,旨在提升都市區醫療機構的診斷能力。
提高家用檢測套組的易用性
人們正在尋求更便捷的醫療保健方式,家用檢測套組的需求日益成長,因為它們使人們無需頻繁前往醫療機構即可追蹤甲狀腺狀況。科技的不斷進步使家用檢測更加可靠和準確,從而增強了人們自主管理自身健康的能力。對於那些因地理位置或時間限制而難以獲得傳統醫療服務的人來說,這一趨勢尤其具有吸引力。此外,在家舒適檢測的便利性促使更多人接受甲狀腺篩檢,為甲狀腺功能檢測市場帶來了光明的前景。 2023年,Healthyr與沃爾瑪合作推出了六款家用乾血斑檢測套組,目前已在沃爾瑪實體店銷售。這些檢測涵蓋了廣泛的健康領域,包括整體健康狀況、膽固醇、糖化血紅蛋白(HbA1c)和血糖值、甲狀腺功能以及性行為感染感染(STI),可透過線上管道或沃爾瑪1200多家門市購買。該計畫旨在透過提供便利的檢測方式,幫助人們更好地掌控自身健康。
提高意識和預防醫學
隨著醫療保健系統向預防策略轉變,甲狀腺疾病和其他慢性病的早期發現和治療變得日益重要。提高宣傳活動對甲狀腺健康重要性的認知和進行的教育活動,鼓勵人們定期篩檢,尤其是在女性和老年人等高危險群中。透過在藥局等日常場所推廣自我檢測,這些努力正在推動人們自主管理健康的趨勢。隨著越來越多的人認知到定期甲狀腺篩檢在整體健康管理中的價值,這種預防性方法正在推動甲狀腺功能檢測市場的成長。 2023年,2San和Phoenix Healthcare在藥局推出了一系列自我診斷測試,包括甲狀腺檢測,以改善個人醫療保健。這些測試在380家Rowlands Pharmacy藥局和5200家Numark獨立藥局提供。其目標是使自我檢測更加普及,使人們能夠及早發現健康問題並在需要時尋求幫助。
The global thyroid function test market size reached USD 1.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 4.73% during 2026-2034. The growing advancements in testing devices for enhancing precision, speed, and reliability, rising demand for at-home testing kits among individuals, and increasing emphasis on early detection and treatment of thyroid disorders are some of the factors impelling the market growth.
Advances in Diagnostic Technologies
Innovations, like automated testing systems, high-throughput analyzers, and POC testing devices, are enhancing the precision, speed, and ease of thyroid testing. These technologies allow healthcare providers to provide faster outcomes, making it easier to diagnose and treat thyroid disorders. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in diagnostic tools is improving the predictive precision of thyroid tests, leading to a higher level of tailored patient treatment. Furthermore, the creation of testing kits for use at home are simplifying the process of monitoring thyroid health for patients, particularly those in remote locations or individuals experiencing mobility challenges. The growing advancements in testing technology are driving the thyroid function test demand in healthcare settings. In 2023, Cipla revealed Cippoint, a device for POC testing that offered rapid testing for various health issues, such as cardiac markers, diabetes, and thyroid function. CE IVD approved, the device produced outcomes within a 3 to 15 minutes timeframe, aiding in faster clinical decision-making. Created for simplicity, Cippoint strived to improve diagnostic abilities in urban and rural healthcare environments.
Increasing Accessibility of At-Home Testing Kits
Individuals are looking for convenient healthcare options, which is driving the demand for at-home testing kits because of their ability to track thyroid without the need for frequent laboratory visits. The continuous technological progress is making home testing options more dependable and precise, empowering individuals to manage their health actively. This trend is particularly appealing to those who may have difficulty accessing traditional healthcare services because of geographical or time constraints. Furthermore, the ability to perform tests comfortably at home is encouraging more people to undergo thyroid screening, offering a favorable thyroid function test market outlook. In 2023, Healthyr introduced six dried blood spot test kits for home use in partnership with Walmart, marking their debut in brick-and-mortar stores. The available tests cover various health aspects like general health, cholesterol, HbA1c + glucose, thyroid function, and sexually transmitted infections (STIs), and can be purchased online or at over 1,200 Walmart stores. This project seeks to enable people to manage their health by offering convenient and easily accessible testing options.
Growing Awareness and Preventive Healthcare
With healthcare systems moving towards proactive strategies, there is an emphasis on early detection and treatment of thyroid disorders and other chronic conditions. Public awareness campaigns and educational initiatives about the significance of thyroid health are encouraging individuals to seek regular screenings, particularly those at higher risk, such as women and older adults. By promoting self-testing in everyday settings like pharmacies, these efforts contribute to the growing trend of empowering people to take control of their health. This proactive approach is supporting the thyroid function test market growth, as more individuals recognize the value of routine thyroid screening for overall health management. In 2023, 2San and Phoenix Healthcare introduced a variety of self-diagnostic tests in pharmacies, including a thyroid test, to improve individual health care. These tests were made available at 380 Rowlands Pharmacy branches and 5,200 Numark independent pharmacies. The goal was to make self-testing more common, enabling people to detect health problems early and seek help as needed.
TSH tests account for the majority of the market share
TSH tests dominate the market because of their widespread use in diagnosing and monitoring thyroid disorders. Thyroid stimulating hormone (TSH) tests are the primary diagnostic tool for detecting both hypothyroidism and hyperthyroidism, as they measure the hormone that regulates the thyroid gland's function. Clinicians prefer using TSH tests for initial thyroid screenings and routine monitoring due to their accuracy, reliability, and cost-effectiveness. The extensive usage and reliability of TSH tests notably contribute to the overall thyroid function test market size, making it a dominant segment in the industry.
Hypothyroidism holds the largest share of the industry
Hypothyroidism represents the largest segment attributed to its high prevalence worldwide and the requirement for frequent monitoring. Hypothyroidism is the result of inadequate hormone production by the thyroid gland, causing symptoms like tiredness, increased weight, and feelings of sadness. The condition is particularly common in older adults and women, with a growing number of cases being diagnosed due to increased healthcare awareness and routine screenings. Hypothyroidism requires continuous monitoring of hormone levels through regular thyroid function testing, which is driving the demand for these tests. In 2024, Niloufer Hospital in Hyderabad initiated a newborn screening program to identify serious genetic disorders like congenital hypothyroidism and G6PD deficiency. The screening includes a heel prick test done between 24 and 48 hours after birth, with results typically ready in five to seven days. This project is a component of a larger campaign to enhance the early diagnosis and management of rare diseases in India.
Hospitals represent the leading market segment
Hospitals hold the biggest market share because of the large patient volume and the presence of advanced diagnostic facilities. Hospitals are commonly the main source of treatment for individuals with thyroid issues, providing a range of services such as specialized endocrinology units and advanced testing tools. Furthermore, hospitals often deal with more intricate situations like thyroid surgeries and cancer treatments that necessitate continuous monitoring of thyroid function. As a result, the thyroid function test market value is rising, driven by the growing demand for comprehensive diagnostic and monitoring solutions among patients within hospital settings.
North America leads the market, accounting for the largest thyroid function test market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for thyroid function test.
North America dominates the market because of advanced healthcare facilities, high healthcare expenditure, and a large population with thyroid issues. The strong focus on preventive healthcare and regular screenings is driving the demand for thyroid function tests. Additionally, the prevalence of autoimmune diseases, such as Hashimoto's thyroiditis and Graves' disease , is relatively high in North America, further driving the need for consistent thyroid monitoring. The presence of key market players and continuous research and innovation in diagnostic technologies is bolstering the market growth. The American Cancer Society predicts around 44,020 new thyroid cancer cases in the United States in 2024, including 12,500 in men and 31,520 in women. Moreover, the estimates suggest about 2,170 fatalities due to thyroid cancer, with 990 in males and 1,180 in females.